A first in man ,crossover study to assess pharmacokinetics, safety and tolerability of escalating single and multiple doses of GS-9876 in healthy subjects
Latest Information Update: 01 Feb 2017
At a glance
- Drugs Lanraplenib (Primary)
- Indications Rheumatoid arthritis
- Focus Adverse reactions; First in man; Pharmacokinetics
- 01 Feb 2017 New trial record